GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

Search

India Globalization Capital Inc

Gesloten

0.3

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.3

Max

0.31

Belangrijke statistieken

By Trading Economics

Inkomsten

-112K

-1.8M

Verkoop

-155K

257K

Winstmarge

-711.673

Werknemers

67

EBITDA

-106K

-1.7M

Dividenden

By Dow Jones

Volgende Winsten

20 jun 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

25M

Vorige openingsprijs

0.3

Vorige sluitingsprijs

0.3

India Globalization Capital Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 sep 2024, 04:00 UTC

Top Nieuws

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

Peer Vergelijking

Prijswijziging

India Globalization Capital Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.